BCAR1: Breast Cancer Anti-Estrogen Resistance 1

A scaffold protein involved in cell migration, adhesion, and cancer progression

Gene Information Card

Symbol BCAR1
Full Name Breast Cancer Anti-Estrogen Resistance 1
Gene Type Protein coding
Chromosomal Location 16q23.1
NCBI Gene ID 9564 ncbi.nlm.nih.gov/gene/9564
Ensembl ID ENSG00000103197
UniProt ID P56979
OMIM ID 604402
HGNC ID HGNC:972
Aliases CAS, CASS1, p130Cas

Description

BCAR1 (Breast Cancer Anti-Estrogen Resistance 1) encodes a scaffold protein, p130Cas, that localizes to focal adhesions and regulates intracellular signaling pathways involved in cell migration, adhesion, proliferation, and survival. It is frequently overexpressed or mutated in various cancers, contributing to anti-estrogen resistance in breast cancer and promoting metastatic progression.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast cancer (anti-estrogen resistance) Overexpression of BCAR1 enhances signaling through the PI3K/AKT and MAPK pathways, bypassing estrogen receptor dependence PMID: 10652318; COSMIC
Ovarian cancer BCAR1 amplification and overexpression promote cell migration and invasion via Src-mediated phosphorylation PMID: 19137010; COSMIC
Colorectal cancer BCAR1 upregulation correlates with poor prognosis and increased metastatic potential through FAK signaling PMID: 21573173; COSMIC
Lung cancer BCAR1 expression is associated with tumor progression and resistance to tyrosine kinase inhibitors PMID: 24947989; COSMIC

Expression Profile

Tissue Expression
Tissue nTPM level
Breast 12.5 Medium
Lung 8.3 Low
Colon 15.2 Medium
Ovary 10.1 Medium
Brain 4.7 Low
Cell Line Expression
Cell Line nTPM Notes
MCF7 (breast cancer) 18.4 High expression; associated with anti-estrogen resistance
A549 (lung cancer) 9.8 Moderate expression
HCT116 (colorectal cancer) 14.2 High expression
OVCAR3 (ovarian cancer) 11.5 Moderate expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1234G>A (p.Glu412Lys) Missense 0.2% (COSMIC) Potential gain-of-function; increased cell migration
c.789_790insC (p.Arg264Profs*13) Frameshift 0.1% (COSMIC) Loss-of-function; reduced protein stability
c.1567C>T (p.Arg523Trp) Missense 0.3% (COSMIC) Unknown; located in SH3 domain
Mutation functional classification

Loss of Function (LOF)

Frameshift mutations (e.g., p.Arg264Profs*13) lead to truncated protein and loss of scaffold function.

Gain of Function (GOF)

Missense mutations (e.g., p.Glu412Lys) may enhance phosphorylation and downstream signaling.

Dominant Negative (DN)

No confirmed dominant-negative mutations reported in BCAR1.

Pathways

FAK signaling (Reactome: R-HSA-446728)
Integrin signaling (Reactome: R-HSA-354192)
PI3K/AKT signaling (Reactome: R-HSA-1257604)
MAPK signaling (Reactome: R-HSA-5673001)

Protein Summary

BCAR1 encodes p130Cas, a 130 kDa scaffold protein containing an SH3 domain, a proline-rich region, and multiple tyrosine phosphorylation sites. It localizes to focal adhesions and interacts with FAK, Src, and Crk to regulate cytoskeletal dynamics, cell migration, and survival. Phosphorylation by Src family kinases creates docking sites for downstream effectors, linking integrin and growth factor signaling to cancer progression.

Related Products

Product name Cat.No. Species Gene ID
BCAR1 Knockout HEK293 Cell Line EDJ-KQ1304 Human 9564 Details Get a Quote
BCAR1 Knockout A-549 Cell Line EDJ-KQ20721 Human 9564 Details Get a Quote
BCAR1 Knockout HCT 116 Cell Line EDJ-KQ20722 Human 9564 Details Get a Quote
BCAR1 Knockout HeLa Cell Line EDJ-KQ20723 Human 9564 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: